Skip to main content
OpenTrials
Completed

NCT Number: NCT03088306

Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients

Patients presenting for lumbar spine surgery experience pain related to their spine condition. Following surgery, these patients also experience surgical pain resulting from disruption of skin, muscle tissue, vertebrae, intervertebral discs, and facet joints. This pain is often treated with opioid medications - with roughly 40% of patient experiencing sub-optimal pain management. Adequate pain control has become a top priority among professional societies, healthcare systems, and accrediting agencies. The current proposal will provide this critical evidence of feasibility and acceptability of a multi-modal pain management plan for patients undergoing lumbar spine surgery. Additionally, this study will provide critical preliminary data to compare the effectiveness of protocol-driven multi-modal pain management to control post-operative pain, reduce opioid medication use, and improve physical activity, sleep, and health.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Johns Hopkins University School of Medicine

Baltimore, Maryland, 21287, United States

About this study

Patients presenting for lumbar spine surgery experience pain related to their spine condition. Following surgery, these patients also experience surgical pain resulting from disruption of skin, muscle tissue, vertebrae, intervertebral discs, and facet joints. Proper pain management is necessary to reduce pain-related and medication side effects and to promote rehabilitation. This pain is often treated with opioid medications - with roughly 40% of patient experiencing sub-optimal pain management. Adequate pain control has become a top priority among professional societies, healthcare systems, and accrediting agencies.

Multi-modal pain management strategies have been proposed to (1) control pre-operative pain related to spine pathology; (2) employ non-opioid medication peri-operatively to pre-empt post-operative surgical pain; and (3) monitor and control pain intensity before and after surgery. There is a demonstrated lack of evidence regarding optimal post-operative protocols and pathways. The investigators have planned a randomized clinical trial to compare the effectiveness of two methods of peri-operative pain management to reduce post-operative pain and opioid use among patients undergoing lumbar spine surgery.

Prior to submission to National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), or Patient Centered Outcomes Research Institute (PCORI), it is necessary to demonstrate the feasibility and acceptability of the trial protocol. The current proposal will provide this critical evidence of feasibility and acceptability of a multi-modal pain management plan for patients undergoing lumbar spine surgery. Additionally, this study will provide critical preliminary data to compare the effectiveness of protocol-driven multi-modal pain management to control post-operative pain, reduce opioid medication use, and improve physical activity, sleep, and health.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Eligible participants will be English-speaking adults who are presenting to a spine surgeon (orthopaedic or neurosurgeon) for surgical treatment of a lumbar degenerative condition (spinal stenosis, spondylosis with or without myelopathy, and degenerative spondylolisthesis) using laminectomy with or without arthrodesis (i.e. fusion).

Exclusion criteria

  • A microsurgical technique as the primary procedure, such as an isolated laminotomy or microdiscectomy.
  • Spinal deformity as the primary indication for surgery.
  • Spine surgery secondary to pseudarthrosis, trauma, infection, or tumor.
  • Back and/or lower extremity pain < 3 months indicating no history of sub-acute or chronic pain.
  • History of neurological disorder or disease, resulting in moderate to severe movement dysfunction.
  • Presence of schizophrenia or other psychotic disorder.
  • Patient refusal to participate.
  • Known allergic reactions to any of the study medications
  • Surgery under a workman's compensation claim.
  • Not able to return to clinic for standard follow-up visits with surgeon.
  • Unable to provide a stable address and access to a telephone.

Treatment and study plan

Standard analgesia use [Oxygen]

Drug

A protocol directed and clinically appropriate post-operative analgesia. In this study, standard post-operative analgesia is defined as: oxygen, volatile anesthesia, fentanyl, hydromorphone.

Standard analgesia use [Hydromorphone]

Drug

A protocol directed and clinically appropriate post-operative analgesia. In this study, standard post-operative analgesia is defined as: oxygen, volatile anesthesia, fentanyl, hydromorphone.

Standard analgesia use [Volatile Anesthesia]

Drug

A protocol directed and clinically appropriate post-operative analgesia. In this study, standard post-operative analgesia is defined as: oxygen, volatile anesthesia, fentanyl, hydromorphone.

Standard analgesia use [Fentanyl]

Drug

A protocol directed and clinically appropriate post-operative analgesia. In this study, standard post-operative analgesia is defined as: oxygen, volatile anesthesia, fentanyl, hydromorphone.

Multi-modal pain management [Acetaminophen + Gabapentin]

Drug

Administration of acetaminophen (1 gm po) plus gabapentin (600-1200 mg po) in the preparation area prior to surgery; pre-induction opioid titration with fentanyl until pain is relieved and/or respiratory depression ensues; intravenous ketamine (1 mg/kg load prior to incision then 10 mcg/kg/min) during surgery; acetaminophen, valium plus gabapentin during hospitalization; and prescription for acetaminophen, valium plus gabapentin at discharge.

Multi-modal pain management [Fentanyl]

Drug

Administration of acetaminophen (1 gm po) plus gabapentin (600-1200 mg po) in the preparation area prior to surgery; pre-induction opioid titration with fentanyl until pain is relieved and/or respiratory depression ensues; intravenous ketamine (1 mg/kg load prior to incision then 10 mcg/kg/min) during surgery; acetaminophen, valium plus gabapentin during hospitalization; and prescription for acetaminophen, valium plus gabapentin at discharge.

Multi-modal pain management [Intravenous Ketamine]

Drug

Administration of acetaminophen (1 gm po) plus gabapentin (600-1200 mg po) in the preparation area prior to surgery; pre-induction opioid titration with fentanyl until pain is relieved and/or respiratory depression ensues; intravenous ketamine (1 mg/kg load prior to incision then 10 mcg/kg/min) during surgery; acetaminophen, valium plus gabapentin during hospitalization; and prescription for acetaminophen, valium plus gabapentin at discharge.

Multi-modal pain management [Valium + Gabapentin]

Drug

Administration of acetaminophen (1 gm po) plus gabapentin (600-1200 mg po) in the preparation area prior to surgery; pre-induction opioid titration with fentanyl until pain is relieved and/or respiratory depression ensues; intravenous ketamine (1 mg/kg load prior to incision then 10 mcg/kg/min) during surgery; acetaminophen, valium plus gabapentin during hospitalization; and prescription for acetaminophen, valium plus gabapentin at discharge.

Primary outcomes

  1. Number of participants undergoing lumbar spine surgery with complete follow-up

    Time frame: 52 week

    Number of participants undergoing lumbar spine surgery with complete follow-up

Secondary outcomes

  1. Patient controlled analgesia (PCA) pump use

    Time frame: during surgical hospitalization, up to 12 weeks

    Total morphine equivalent of opioids administered by the PCA pump

  2. Opioid medication use

    Time frame: up to 90 days

    How many patients were prescribed and using opioid medication over the 90 days after hospital discharge?

  3. Patient Reported Outcomes Measurement Information System (PROMIS) Pain

    Time frame: at 6 and 12 weeks

    Measure of pain intensity; Range 0 - 100; Population mean 50, standard deviation 10

  4. PROMIS Physical Function

    Time frame: at 6 and 12 weeks

    Measure of physical function; Range 0 - 100; Population mean 50, standard deviation 10

  5. PROMIS Fatigue

    Time frame: at 6 and 12 weeks

    Measure of fatigue; Range 0 - 100; Population mean 50, standard deviation 10

  6. PROMIS Anxiety

    Time frame: at 6 and 12 weeks

    Measure of anxiety; Range 0 - 100; Population mean 50, standard deviation 10

  7. PROMIS Depression

    Time frame: at 6 and 12 weeks

    Measure of depression; Range 0 - 100; Population mean 50, standard deviation 10

  8. PROMIS Sleep Disturbance

    Time frame: at 6 and 12 weeks

    Measure of sleep disturbance; Range 0 - 100; Population mean 50, standard deviation 10

  9. PROMIS Satisfaction with Social Roles

    Time frame: at 6 and 12 weeks

    Measure of satisfaction with social roles; Range 0 - 100; Population mean 50, standard deviation 10

  10. Health status (Medical Outcome Study Short Form 12, version 2)

    Time frame: at 6 and 12 weeks

    Measure of physical and mental health; Range 0 - 100; Population mean 50, standard deviation 10

  11. Oswestry Disability Index (ODI)

    Time frame: at 6 and 12 weeks

    Measure of pain-related disability; Range 0% - 100%; Scores greater than 30% indicative of moderate pain-related disability

Sponsors and collaborators

Lead sponsor

Johns Hopkins University

Other

Collaborators

  • North American Spine Society

Registry information

Official study title

Comparative Effectiveness of Multi-modal Pain Management Versus Standard Intra- and Post-operative Analgesia: Randomized Controlled Clinical Trial to Reduce Post-operative Pain and Opioid Use Among Patients Undergoing Lumbar Spine Surgery

Acronym: IPaRO

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Mar 23, 2017
Registry last updated
Oct 16, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.